Overview

Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
0
Participant gender:
All
Summary
Utilization of nitric oxide (NO) therapy has been related to a trend towards short term improvement in very premature infants. A two year follow-up of children treated soon after birth with NO in the neonatal period, suggests that a significant improvement in neurodevelopmental outcome might occur. This study aims to evaluate follow-up at 6 years, in respiratory and neurodevelopmental outcome, of children born very prematurely, some of them having been treated with nitric oxide in the neonatal period.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Maternite Regionale Universitaire
Treatments:
Nitric Oxide
Criteria
Inclusion Criteria:

- All infants included at birth in a randomized controlled trial using early nitric
oxide therapy

Exclusion Criteria:

- Parental refusal